Arvizu RF, Ramírez CE, Valencia HAM, Toledo BME, Mena CCA, Trujillo RB

Language: Spanish
References: 35
Page: 228-233
PDF size: 155.42 Kb.

ABSTRACT

Cutaneous vascular lesions are common in children, and are a frequent cause for consultation. They are classified into vascular tumors and malformations. Infantile hemangiomas are the most common tumors, characterized by their rapid growth in the first 6-12 months of age, and then have an involution phase. Fifty percent of patients with these lesions have a complete involution within 5 years. By contrast, vascular malformations are present from birth, increasing proportionally with the child’s growth, with no spontaneous regression. The management of these lesions is complicated because there is a large percentage of diagnostic error, the treatment will be different for each type, and there are no gold standard therapeutic options .

REFERENCES

1. MacFie CC, Jeffery B. “Diagnosis of vascular skin lesions in children: An audit and review”. Pediatr Dermatol 2008; 25(1): 7-12.

2. Mulliken JB, Glowacki J. “Hemangiomas and vascular malformations in infants and children. A classification base on endotelial characteristics”. Plast Reconstr Surg 1982; 69: 412-442.

3. Legiehn GM, Heran MK. “Venous malformations: Classification, development, diagnosis, and interventional radiologic management”. Radiol Clin N Am 2008; 46: 545-597.

4. Christison-Lagay ER, Fishman ST. “Vascular anomalies”. Surg Clin N Am 2006; 86: 393-425.

5. Trujillo B, Zerpa VR, Hernández MI, Pasquali TP, Castro-Ron G. “Tratamiento intralesión de hemangiomas perioculares”. Gac Méd Caracas 2000; 108(2): 213-219.

6. Trujillo B. “Manejo de lesiones vasculares benignas”. Gac Med Caracas 2008; 116(2): 134-142.

7. Belzunce A, Casellas M. “Complicaciones en la evolución de los hemangiomas y malformaciones vasculares”. An Sist Sanit Navar 2004; 24 (Supl 1): 57-69.

8. Buckner AL, Frieden IJ. “Infantile hemangiomas”. J Am Acad Dermatol 2006; 55: 671-682.

9. Tobón A, Aluma MA, Jiménez G. “Hemangiomas infantiles”. Rev Asoc Col Dermatol 2008; 16(4): 277-287.

10. Chen MT, Yeong EK, Horng SY. “Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases”. J Pediatr Surg 2000; 35: 420-423.

11. Garzon MC, Lucky AW, Hawrot A, Frieden IJ. “Ultrapotent topical corticosteroid treatment of hemangiomas of infancy”. J Am Acad Dermatol 2005; 52: 281-286.

12. Cruz OA, Zarnegar SR, Myers SE. “Treatment of periocular capillary hemangioma with topical clobetasol propionate”. Ophthalmology 1995; 102: 2012-2015.

13. Elsas FJ, Lewis AR. “Topical treatment of periocular capillary hemangiomas”. J Pediatr Ophthalmol Strabismus 1994; 31: 153-156.

14. Ho NT, Lansang P, Pope E. “Topical imiquimod in the treatment of infantile hemangiomas: A retrospective study”. J Am Acad Dermatol 2007; 56: 63-68.

15. Senchak AJ, Dann M, Cable B, Bessinger G. “Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases”. Ear Nose Throat J 2010; 89(3): E21-E25.

16. Bennett, ML, Fleischer, AB, Chamlin, SL, et al. “Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation (Structured abstract)”. Arch Dermatol 2001; 137: 1208-1213

17. Christison-Lagay ER, Fishman ST. “Vascular Anomalies”. Surg Clin N Am 2006; 86: 393-425.

18. Perez, J, Pardo, J, Gomez, C. “Vincristine–an effective treatment of corticoid-resistant life-threatening infantile hemangiomas”. Acta Oncol 2002; 41 (2): 197-199.

19. Moore, J, Lee, M, Garzon, M, et al. “Effective therapy of a vascular tumor of infancy with vincristine”. J Pediatr Surg 2001; 36: 1273-1276.

20. Lloret P. “Tratamiento médico de los hemangiomas”. An Sist Sanit Navar 2004; 27: 81-92.

21. Drolet BA, Esterly, NB, Frieden, IJ. “Hemangiomas in children”. N Engl J Med 1999; 341: 173.

22. Michaud, AP, Bauman, NM, Burke, DK, et al. “Spastic diplegia and other motor disturbances in infants receiving interferon-alpha”. Laryngoscope 2004; 114: 1231-1236.

23. Léauté-Labréze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. “Propranolol for severe haemangiomas of infancy”. N Engl J Med 2008; 358: 2649-2651.

24. Zimmermann AP, Wiegand S, Werner JA, Eivazi B. “Propranolol therapy for infantile haemangiomas: Review of the literature”. Int J Pediatr Otorhinolaryngology 2010; 74: 338-342.

25. Lawley LP, Siegfried E, Todd JL. “Propranolol treatment for hemangioma of infancy: Risk and Recommendations”. Pediatric Dermatology 2009; 26(5): 610-614.

26. Buckmiller L. “Propranolol treatment for infantile hemangiomas”. Curr Opin Otolaryngol Head Neck Surg 2009; 17: 458-459.

27. Sánchez I, Mihm MC, Waner M. “Láser y luz pulsada en el tratamiento de hemangiomas infantiles y malformaciones vasculares”. An Sist Sanit Navar 2004; 27: 103-115.

28. Warner M, Murillo J, Aubá C, Hontanilla B. “Tratamiento quirúrgico de los hemangiomas”. An Sist Sanit Navar 2004; 27: 93-101.

29. McHeik NJ, Renauld V, Duport G, Vergnes P, Levard G. “Surgical treatment of haemangioma in infants”. Br J Plast Surg 2005; 58: 1067- 1072.

30. Garzon MC, Huang JT, Enjolras O, Frieden IJ. “Vascular malformations”. J Am Acad Dermatol 2007; 56: 353-370.

31. Lee BB. “New approaches to the treatment of congenital vascular malformations (CVMs): A single centre experience”. Eur J Vas Endovasc Surg 2005; 30: 184-197.

32. Legiehn G, Heran M. “Venous malformations: Classification, development, diagnosis and interventional radiologic management”. Radiol Clin N Am 2008; 46: 545-597.

33. Cabrera J, Redondo P. “Tratamiento esclerosante de las malformaciones vasculares”. An Sist Navar 2004; 27: 117-126.

34. Saitta P, Krishnamarthy K, Brown L. “Bleomycin in dermatology: A review of intralesional applications”. Dermatol Surg 2008; 34: 1299-1313.

35. Mathur N, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T. “Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck”. Int J Pediatr Otorhinolaryngol 2005; 26: 75-80.